Nci Clinical and Translational Exploratory/Developmental Tender
Notice for Nci Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) in USA. The reference ID of the tender is 68988214 and it is closing on 01 Jul 2025.
Tender Details
- Country: USA
- Summary: Nci Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- UST Ref No: 68988214
- Deadline: 01 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-216
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
CFDA Number : 93.393 -- Cancer Cause and Prevention Research93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.396 -- Cancer Biology Research93.399 -- Cancer Control
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jul 01, 2025
Posted Date : Jul 14, 2022
Description: This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (pre-clinical or clinical). - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNci Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nci Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 68988214 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.
- 1,000+ Tenders
- Verified Tenders Only
- New Tenders Every Day
- Tenders Result Data
- Archive & Historical Tenders Access
- Consultants for RFI/RFP/RFQ
- Tender Notifications & Alerts
- Search, Sort, and Filter Tenders
- Bidding Assistance & Consulting
- Customer Support
- Publish your Tenders
- Export data to Excel
- API for Tender Data
- Tender Documents
Fill out the form below and you will receive a call from us within 24 hours.
Get FREE SAMPLE TENDERS from USA in your email inbox.
Copyright © 2014-2026 USARFP.com. All Rights Reserved.